Direct Oral Anticoagulants vs Low-Molecular-Weight Heparin and Recurrent VTE in Patients With Cancer

Deborah Schrag, Hajime Uno, Rachel Rosovsky, +13

JAMA

Binding, inactivation, and adhesion forces between antimicrobial peptide cecropin P1 and pathogenic E. coli

Joshua D. Strauss, Andrea L. Kadilak, Christine Cronin, +2

Colloids and Surfaces B Biointerfaces

BiochemistryProtein FoldingCell AdhesionVirulence FactorPathogenic E. Coli +3

Implementation of patient-reported outcomes for symptom management in oncology practice through the SIMPRO research consortium: a protocol for a pragmatic type II hybrid effectiveness-implementation multi-center cluster-randomized stepped wedge trial

Michael J. Hassett, Sandra L. Wong, Raymond U. Osarogiagbon, +6

Trials

The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel method

Justin D. Smith, Wynne E. Norton, Sandra A. Mitchell, +13

Implementation Science Communications

A stakeholder-driven approach to improve the informed consent process for palliative chemotherapy

Andrea C. Enzinger, Jennifer Wind, Elizabeth Frank, +8

Patient Education and Counseling

Palliative CareClinical SettingsMedical Decision MakingPalliative ChemotherapyOncology +10

The comparative effectiveness of direct oral anti-coagulants and low molecular weight heparins for prevention of recurrent venous thromboembolism in cancer: The CANVAS pragmatic randomized trial.

Deborah Schrag, Hajime Uno, Rachel Rosovsky, +12

Journal of Clinical Oncology

Recurrent VtePatient SelectionClinical EndpointPharmacotherapyCancer Patients +24

Cancer Caregivers’ Prognostic and End-of-Life Communication Needs and Experiences and their Impact

Anny Fenton, Kalen Fletcher, Deniz Kizildag, +7

Journal of Pain and Symptom Management

Palliative CareNursingEnd-of-life Communication NeedsEnd-of-life CareHealth Communication +6

Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients With Advanced Cancer

Andrea C. Enzinger, Hajime Uno, Nadine J. McCleary, +9

JAMA Oncology

Systematic symptom management in the IMPACT Consortium: rationale and design for 3 effectiveness-implementation trials

Ashley Wilder Smith, Lisa DiMartino, Sofia F. Garcia, +84

JNCI Cancer Spectrum

Disease ManagementEffectiveness-implementation TrialsImplementation ScienceClinical TrialsDigital Health +17

The Effect of Disclosing Life Expectancy Information on Patients' Prognostic Understanding: Secondary Outcomes From a Multicenter Randomized Trial of a Palliative Chemotherapy Educational Intervention

Andrea C. Enzinger, Hajime Uno, Nadine J. McCleary, +8

Journal of Pain and Symptom Management